Healthcare · Biotech & Pharma
Altos Labs
Series C
Implied valuation
$00 B
Live tracking
IPO Odds00 %modeled estimate
Probability modeled from funding stage, momentum & liquidity signals.
Valuation Trajectory
982×
since foundingJun 2016Jun 2026
Funding-round staircase from founding · log scale. Modeled round ladder anchored to the current valuation — illustrative, not a published figure.
IPO Model Drivers
Why the odds read this way
Valuation momentum
+259.5% trailingFinancing stage
Series CScale & liquidity pull
Private-market valuationFactor weights are illustrative decompositions of the modeled IPO probability, not guarantees.
Down-Round Risk
Valuation downside pressure
Moderate
Mixed signals — limited valuation history with 34% modeled IPO odds keep down-round risk in the middle band.
Asset brief
Altos Labs is a Healthcare · Biotech & Pharma company last marked at $6.33B. Stage: Series C. No verified market-moving events in the last 30 days.
Capital Timeline
Funding & liquidity milestones
Series C
$6.33B
Backed by
No disclosed investors yet.
Comparables
Healthcare
Signals
No recent signals for Altos Labs.